posdinemab

News

Hopes that anti-tau drugs could emerge as treatments for Alzheimer's have been dented by the failure of a phase 2b trial of J&J's posdinemab.

News

The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.